1-1 of 1
Keywords: High-risk non-muscle invasive bladder cancer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Predictive Factors for Time to Progression after Hyperthermic Mitomycin C Treatment for High-Risk Non-Muscle Invasive Urothelial Carcinoma of the Bladder: An Observational Cohort Study of 97 Patients

Available to Purchase
Subject Area:
Further Areas
Prasanna Sooriakumaran, Virginia Chiocchia, Susan Dutton, Aakash Pai, Benjamin E. Ayres, Pieter Le Roux, Michael Swinn, Michael Bailey, Matthew J.A. Perry, Rami Issa
Journal: Urologia Internationalis
Urol Int (2016) 96 (1): 83–90.
https://doi.org/10.1159/000435788
Published Online: 06 August 2015
...Prasanna Sooriakumaran; Virginia Chiocchia; Susan Dutton; Aakash Pai; Benjamin E. Ayres; Pieter Le Roux; Michael Swinn; Michael Bailey; Matthew J.A. Perry; Rami Issa Introduction: Hyperthermic mitomycin (HM) is a novel treatment modality for selected patients with high-risk non-muscle invasive...
View article titled, Predictive Factors for Time to Progression after Hyperthermic Mitomycin C Treatment for High-Risk Non-Muscle Invasive Urothelial Carcinoma of the Bladder: An Observational Cohort Study of 97 Patients
Open the PDF for Predictive Factors for Time to Progression after Hyperthermic Mitomycin C Treatment for High-Risk Non-Muscle Invasive Urothelial Carcinoma of the Bladder: An Observational Cohort Study of 97 Patients in another window